This is a prospective, multicenter, non-randomized, parallel design comparing a primary efficacy endpoint between subjects undergoing immediate post-mastectomy breast reconstruction with a breast implant and Strattice™ Reconstructive Tissue Matrix (TM) and subjects undergoing immediate, two-stage post-mastectomy breast reconstruction, where the initially placed expander will be exchanged for a breast implant only, without any type of reinforcement.